Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 169-174

  Leegwater, P A J ^a   De Abreu, R A ^a   Albertioni, F ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

2 chloro 2' arabino fluoro 2' deoxyadenosine; 2 chloro 2' deoxyadenosine; 5 methylcytosine; DNA methylation

Indexed keywords

2' ARABINOFLUORO 2' DEOXYADENOSINE; BISULFITE; CLADRIBINE; DEOXYADENOSINE DERIVATIVE; DEOXYCYTIDINE KINASE; DNA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; DNA METHYLATION; DNA SEQUENCE; DRUG RESISTANCE; ENZYME ACTIVITY; EXON; HUMAN; HUMAN CELL; INTRON; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

ARA;

EID: 0032516637     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00131-1     Document Type: Article

References (12)

1. Bryson H., Sorkin E. Cladribine. A review of its pharmacodynamics, pharmacokinetics and therapeutic potential in the treatment of haematological malignancies. Drugs. 46(5):1993;872-894.
2. Montgomery J.A., Shortnacy F.A., Clayton S.D., Riordan J.M., Secrist J.D. Synthesis and biologic activity of 2′-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine. J. Med. Chem. 35(2):1992;397-401.
3. Carson D.A., Wasson D.B., Esparza L.M., Carrera C.J., Kipps T.J., Cottam H.B. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine. Proc. Natl. Acad. Sci. USA. 89:1992;2970-2974.
4. Parker W.B., Shaddix S.C., Chang C.H., White E.L., Rose L.M., Brockman R.W., Shortnacy A.T., Montgomery J.A., Secrist J.D., Bennett L.J. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5′-triphosphate. Cancer Res. 51(9):1991;2386-2394.
5. Talbot D., Orr R., Serafimowski P., Karrap K. Characterisation of acquired resistance to 2-chloro-2′-deoxyadenosine in lymphoid cell lines. Proc. Am. Assoc. Cancer Res. 34:1993;305.
6. Albertioni F., Reichelova B., Pettersson B., Juliusson G., Liliemark J. Mechanisms of cladribine resistance in a human lymphoid, CCRF-CEM cell line. Assoc. Cancer Res. Annu. Meet. 37(0):1996;316.
7. Albertioni F., Reichelova V., Pettersson B., Eriksson S., Liliemark J. Mechanisms of 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine (CAFdA) resistance in a human lymphoid, CCRF-CEM cell line. Assoc. Cancer Res. Annu. Meet. 38:1997;687.
8. Carson D.A., Wasson D.B., Kaye J., Ullman B., Martin J.D.W., Robins R., Montgomery J.A. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs towards malignant human lymphoblasts in vitro and towards murine L1210 leukemia in vivo. Proc. Natl. Acad. Sci. USA. 77:1980;6865-6869.
9. Antonsson B.E., Avramis V.I., Nyce J., Holcenberg J.S. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCK-. Cancer Res. 47:1987;3672-3678.
10. Clark S.J., Harrison J., Paul C.L., Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22:1994;2990-2997.
11. Leegwater P.A.J., Lambooy L.H.J., De Abreu R.A., Bökkerink J.P.M., van den Heuvel L.P. DNA methylation patterns in the calcitonin gene region at first diagnosis and at relapse of acute lymphoblastic leukemia (ALL). Leukemia. 11:1997;971-978.
12. Dodge J.E., Futscher B.W. Methylation analysis of the deoxycytidine kinase promotor in drug-sensitive and drug-resistant tumor cells. Assoc. Cancer Res. Annu. Meet. 38:1997;180.